startups
Most Read
STAT Plus: Flagship to launch a new startup focused on neurodegenerative conditions, including Parkinson’s
STAT Plus: 4 food allergy immunotherapy companies to watch
STAT Plus: Moderna, making billions from its vaccine, bets on a genome-editing startup
STAT Plus: In the ‘fail fast’ world of biotech, ‘offboarding’ is just as important as onboarding
STAT Plus: In another sign of RNA’s growing popularity, the cancer startup Replicate is relaunching
STAT Plus: Flagship, Orbimed, ARCH, Alta top list of high-performing biotech venture capital firms
STAT Plus: Startup Spotlight: Vigil Neuroscience hopes to eventually target the rare disease ALSP
All Coverage
advertisement
